Emkay Global Financial's research report on Oil India. Oil India clocked Q2FY25 SA EBITDA of Rs21.8bn – an 11% miss, mainly due to higher provisions and lower-than-expected output. The SA PAT miss, however, was lower at 6% on higher Other Income and lower ETR. Crude production rose 5% YoY to 0.88mmt (2% miss), while gas was 3% below estimate at 0.80bcm (down 1% YoY on customer offtake issues).
Open FlipDrugmaker Abbott India reported a rise in second-quarter profit on November 7, helped by strong demand for its gastrointestinal and anti-infective medications. The company, which makes the antacid Digene, reported a profit of 3.59 billion rupees ($42.6 million) for the quarter ended Sept. 30, up nearly 15 percent from last year. Revenue from operations climbed 9.3 percent to 16.33 billion rupees.
Open FlipJK Tyre's Q2 results were negatively impacted by a 16% sales decline in Mexico and 10% currency depreciation, but the outlook is improving due to expected growth in domestic MHCVs, softer rubber prices, and pricing action. The company's profitability is expected to recover from Q4FY25E onwards, and Emkay Global Financial retains a BUY rating with a revised target price of Rs 650.
Open Flip